Protective effects of lipoic acid and mesna on cyclophosphamide-induced haemorrhagic cystitis in mice

Cell Biochem Funct. 2014 Mar;32(2):125-32. doi: 10.1002/cbf.2978. Epub 2013 May 5.

Abstract

The protective roles of lipoic acid (LA)/vitamin C (VC) and mesna on preventing cyclophosphamide (CYP)-induced haemorrhagic cystitis (HC) were investigated. Swiss mice were divided into five groups randomly. HC was induced by a single dose of CYP injection (150-mg kg(-1) bodyweight). Group I was injected with saline (four times in total) throughout as control group. Group II received CYP and three equal doses of saline. Group III received CYP and three doses of mesna, whereas Group IV (or Group V) received CYP, mesna + two doses of VC (or LA). All injections were performed intraperitoneally. After 24 h of cystitis induction, the bladders were collected for all the experiments. Histological characterization showed that CYP injection resulted in severe HC. Reactive oxygen species (ROS) and thiobarbituric acid reactive substances' levels were increased in CYP group. The activities of antioxidant enzymes, e.g. superoxide dismutase, catalase, glutathione S-transferase and glutathione peroxidase, were inhibited significantly in CYP groups, respectively. In addition, activation of c-jun N-terminal kinases (JNK) and p38 mitogen-activated protein kinase (MAPK) may be involved in the mechanism of CYP-induced HC but not extracellular signal regulated kinases (ERK). Significant suppression of p38 phosphorylation on Group V suggests that LA and mesna may have synergistic beneficial effect. In Groups III-V, all the parameters of HC and oxidative stress were inhibited significantly. Taking together, we found that these results illustrated that ROS play an important role on CYP-induced HC and the administration of LA/VC with mesna may have therapeutic potential against CYP-induced bladder HC.

Keywords: cyclophosphamide; haemorrhagic cystitis; lipoic acid; mesna; oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects*
  • Antioxidants / therapeutic use*
  • Ascorbic Acid / therapeutic use
  • Cyclophosphamide / adverse effects*
  • Cystitis / chemically induced
  • Cystitis / metabolism
  • Cystitis / prevention & control*
  • Drug Synergism
  • Hematuria / chemically induced
  • Hematuria / metabolism
  • Hematuria / prevention & control*
  • MAP Kinase Signaling System
  • Mesna / therapeutic use*
  • Mice
  • Organ Size / drug effects
  • Phosphorylation
  • Protective Agents / therapeutic use*
  • Random Allocation
  • Reactive Oxygen Species / metabolism
  • Thioctic Acid / therapeutic use*
  • Urinary Bladder / drug effects
  • Urinary Bladder / metabolism
  • Urinary Bladder / physiopathology

Substances

  • Antineoplastic Agents
  • Antioxidants
  • Protective Agents
  • Reactive Oxygen Species
  • Thioctic Acid
  • Cyclophosphamide
  • Mesna
  • Ascorbic Acid